XORTX Therapeutics Overview
XORTX Therapeutics Discounted Cash Flow
DCF Analysis for XRTX.
Get informed when a big investor buys or sells
+ FollowFair Value
$3.12
Current Fair Value
$3.12
↑ 43.1% Upside
Undervalued by 43.1% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison